BAXALTA INCORPORATED

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 17795
 
  
 
C07K PEPTIDES 12537
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 9674
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 52154
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 3861
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 2798
 
  
 
B01D SEPARATION 19115
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 1485
 
  
 
C12M APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY 1336
 
  
 
A61M DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY 11143

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2017/0369,853 FORMULATION OF SUGAR SOLUTIONS FOR CONTINUOUS ULTRACENTRIFUGATION FOR VIRUS PURIFICATIONJul 11, 17Dec 28, 17[A61K, C12N]
2017/0360,823 NON-ANTICOAGULANT SULFATED OR SULFONATED POLYSACCHARIDESSep 05, 17Dec 21, 17[A61K, C07H, C08B]
2017/0362,300 OLIGOPEPTIDE-FREE CELL CULTURE MEDIAAug 07, 17Dec 21, 17[C12N, C07K]
2017/0281,671 NON-ANTICOAGULANT SULFATED OR SULFONATED SYNTHETIC POLYMERSJun 19, 17Oct 05, 17[A61K]
2017/0267,743 FVIII PEPTIDES FOR IMMUNE TOLERANCE INDUCTION AND IMMUNODIAGNOSTICSNov 02, 16Sep 21, 17[A61K, C12P, G01N, C07K]
2017/0260,498 VIRUS FILTRATION OF CELL CULTURE MEDIAMar 27, 17Sep 14, 17[C12N, C12M, A61L]
2017/0226,487 RECOMBINANT CO-EXPRESSION OF VITAMIN K EPOXIDE REDUCTASE SUBUNIT 1 TO IMPROVE VITAMIN K DEPENDENT PROTEIN EXPRESSIONJan 18, 17Aug 10, 17[C12N]
2017/0227,557 METHOD AND COMPOSITIONS FOR SPECIFICALLY DETECTING PHYSIOLOGICALLY ACCEPTABLE POLYMER MOLECULESJan 16, 17Aug 10, 17[G01N]
2017/0218,051 METHODS TO PRODUCE A HUMAN PLASMA-DERIVED IGG PREPARATION ENRICHED IN BRAIN DISEASE-RELATED NATURAL IGGSDec 20, 16Aug 03, 17[C07K, B01D]
2017/0196,994 MODELS OF THROMBOTIC THROMBOCYTOPENIC PURPURA AND METHODS OF USE THEREOFJan 24, 17Jul 13, 17[A61K, A01K]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
RE46745 Recombinant cell clones having increased stability and methods of making and using the sameDec 11, 14Mar 06, 18[C12P, C12N]
9895434 Chimeric OspA genes, proteins and methods of use thereofFeb 22, 16Feb 20, 18[A61K, C07K]
9896501 Methods to produce a human plasma-derived IgG preparation enriched in brain disease-related natural IgGsMar 14, 14Feb 20, 18[C07K, B01D]
9889248 Syringe storage trayDec 20, 12Feb 13, 18[B01F, A61M]
9873720 TFPI inhibitors and methods of useDec 29, 14Jan 23, 18[A61K, G01N, A61P, C07K]
9873892 Production of fully processed and functional factor X in a furin-secreting mammalian expression systemAug 12, 15Jan 23, 18[A61K, C12P, C12N]
9855331 Stabilization of immunoglobulins through aqueous formulation with histidine at weak acidic to neutral pHJun 20, 14Jan 02, 18[A61K]
9834591 Method of producing recombinant high molecular weight vWF in cell cultureJul 01, 16Dec 05, 17[A61K, C12P, C12N, C07K]
9834593 IgG stimulated remyelination of peripheral nervesFeb 18, 15Dec 05, 17[A61K, C07K]
9808570 Syringe storage trayNov 21, 13Nov 07, 17[B01F, A61M]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2017/0240,867 VITAMIN K EPOXIDE RECYCLING POLYPEPTIDE VKORC1, A THERAPEUTIC TARGET OF COUMARIN AND THEIR DERIVATIVESAbandonedJun 22, 15Aug 24, 17[C12Q, C12N, A01K, C07K]
2017/0210,794 CHARACTERIZATION OF CHO-MIF GENE AND PROTEIN, AND USE THEREOFAbandonedAug 30, 16Jul 27, 17[C12N, C07K]
2017/0153,256 METHODS FOR TREATING BLEEDING DISORDERS USING A PLATELET SUBPOPULATIONAbandonedDec 07, 16Jun 01, 17[C12N, G01N]
2016/0113,932 TREATMENT OF CANCERS USING PI3 KINASE ISOFORM MODULATORSAbandonedMay 30, 14Apr 28, 16[A61K, C12Q]
2016/0114,010 METHODS FOR TREATING BLEEDING DISORDERS USING A PLATELET SUBPOPULATIONAbandonedMar 14, 14Apr 28, 16[A61K, C12N, G01N]
9200031 Real time monitoring and control of protein production processes using impedance spectroscopyWithdrawnDec 09, 11Dec 01, 15[G01N, G01R, C07K]
2015/0309,012 ANTI-MIF ANTIBODY CELL MIGRATION ASSAYAbandonedDec 05, 13Oct 29, 15[G01N, C07K]
2015/0250,873 COMBINATION THERAPY OF ANTI-MIF ANTIBODIES AND GLUCOCORTICOIDSAbandonedApr 16, 13Sep 10, 15[A61K]
2015/0133,644 METHOD TO PRODUCE AN IMMUNOGLOBULIN PREPARATION WITH IMPROVED YIELDAbandonedJun 19, 14May 14, 15[C07K]
2015/0093,411 Chimeric Multivalent Polysaccharide Conjugate VaccinesAbandonedJun 27, 14Apr 02, 15[A61K]
2015/0071,942 COMBINATION THERAPY OF ANTI-MIF ANTIBODIES AND CHEMOTHERAPEUTICSAbandonedApr 16, 13Mar 12, 15[A61K]
2015/0056,657 METHOD OF PRODUCING RECOMBINANT HIGH MOLECULAR WEIGHT vWF IN CELL CULTUREAbandonedSep 03, 14Feb 26, 15[C12N, C07K]
2015/0023,978 ANTI MIF ANTIBODIESAbandonedJan 17, 14Jan 22, 15[C07K]
2015/0010,570 METHODS AND COMPOSITIONS FOR USING MHC CLASS II INVARIANT CHAIN POLYPEPTIDES AS A RECEPTOR FOR MACROPHAGE MIGRATION INHIBITORY FACTORAbandonedJun 04, 14Jan 08, 15[C12N, G01N, C07K]
2014/0232,029 KIT FOR MEASURING THE THROMBIN GENERATION IN A SAMPLE OF A PATIENT'S BLOOD OR PLASMAAbandonedApr 25, 14Aug 21, 14[A61K]
2014/0234,292 Process for Producing a Plasma Protein-Containing MedicamentAbandonedApr 29, 14Aug 21, 14[A61K]
2014/0186,323 FACTOR VIIA-POLYSIALIC ACID CONJUGATES HAVING PROLONGED IN VIVO HALF-LIFEAbandonedDec 20, 13Jul 03, 14[C12N]
2014/0107,320 BLOOD COAGULATION PROTEIN CONJUGATESAbandonedDec 20, 13Apr 17, 14[A61K]
2014/0050,717 Methods for Treating Bleeding DisordersAbandonedAug 29, 13Feb 20, 14[A61K]
2014/0024,808 FACTOR VIII POLYMER CONJUGATESAbandonedFeb 01, 13Jan 23, 14[A61K]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.